Petros Pharmaceuticals, Inc. (PTPI)

NASDAQ: PTPI · IEX Real-Time Price · USD

0.713

+0.033 (4.91%)

At close: May 3, 2024, 4:00 PM

0.700

-0.013 (-1.86%)

After-hours: May 3, 2024, 7:56 PM EDT

Petros Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-13.81	-20.04	-8.99	-20.59	-32.51
Depreciation & Amortization	3.42	5.72	6.98	6.75	5.32
Share-Based Compensation	0.42	1.2	1.31	0	0
Other Operating Activities	-3.3	0.33	-11.16	-1.47	29.73
Operating Cash Flow	-7.63	-12.8	-11.86	-15.31	2.53
Capital Expenditures	0	0	0	-0	-0.07
Investing Cash Flow	0	0	0	-0	-0.07
Share Issuance / Repurchase	15	0	25.76	21.57	0
Debt Issued / Paid	-1.46	-1.62	-7.19	8.73	-3.11
Other Financing Activities	-2	-	-	-	-
Financing Cash Flow	11.54	-1.62	18.57	30.3	-3.11
Net Cash Flow	3.91	-14.42	6.71	14.99	-0.65
Free Cash Flow	-7.63	-12.8	-11.86	-15.31	2.46
Free Cash Flow Margin	-130.99%	-213.57%	-151.86%	-160.15%	15.80%
Free Cash Flow Per Share	-3.50	-6.18	-10.89	-28.67	10.00

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).